Bookbot

Pia Grazdani

Esta serie sigue el viaje médico de una estudiante dedicada mientras navega por el intrincado y exigente mundo de la atención médica. Sé testigo de su crecimiento a través de casos desafiantes, dilemas éticos y triunfos personales dentro de un entorno de alto riesgo. Las narrativas profundizan en la búsqueda incesante del conocimiento, el profundo deseo de curar y los sacrificios inherentes a una carrera dedicada a salvar vidas.

Nano
Death benefit

Orden recomendado de lectura

  1. 1

    Pia Grazdani is an exceptional yet aloof medical student working closely with Columbia University Medical Center's premier scientist. Their cutting edge research could revolutionize health care; creating replacement organs. Thorough her work with the brilliant molecular geneticist Dr Tobias Rothman, Pia knows she will not only be given the chance to fulfil her professional ambitions - but also maybe finally all push aside memories of her difficult, abusive childhood. However, tragedy strikes in the lab. Pia, with the help of infatuated classmate George Wilson, launches an investigation into the unforeseen calamity in the hospital's supposedly secure biosafety lab. Meanwhile, two ex-Wall Street whiz-kids think they have found another lodestone in the nation's multi-trillion dollar life insurance industry, and race to find ways to control the data - and make a killing. And as Pia and George dig deeper into the events at the lab, matters become increasingly suspicious . . .

    Death benefit
  2. 2

    After a tumultuous year in which her mentor is murdered and her estranged father comes back into her life, Pia Grazdani, the embattled medical student from Death Benefit, decides to take a year off from her medical studies and escape New York City. Intrigued by the promise of the burgeoning field of medical technology and the chance to clear her head, Pia takes a job at Nano, LLC, a lavishly funded, security-conscious nanotechnology insititute in the picturesque foothills of the Rockies. Nano, LLC is ahead of the curve in the competitive world of molecular manufacturing, including the construction of microbivores, tiny nano-robots with the ability to gobble up viruses and bacteria. But the corporate campus is a place of secrets. She's warned by her boss not to investigate the other work being done at the gigantic facility, nor to ask questions about the source of the seemingly endless capital that funds the institute's research. And when Pia encounters a fellow employee on a corporate jogging path, suffering the effects of a seizure, she soon realizes she may have literally stumbled upon Nano LLC's human guinea pigs. Is the tech giant on the cusp of one of the biggest medical discoveries of the twenty-first century—a treatment option for millions—or have they already sold out to the highest bidder?

    Nano